Jane Street
EDSA icon

Jane Street’s Edesa Biotech EDSA Stock Holding History

Jane Street’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$210K Sell
49,992
-22,473
-31% -$118K ﹤0.01% 9972
2026
Q2 		$589K Sell
72,465
-43,256
-37% -$390K ﹤0.01% 7648
2026
Q1 		$605K Buy
+115,721
New +$347K ﹤0.01% 7595
2018
Q4 		– Sell
-487
Closed -$28K – 5102
2018
Q3 		$28K Buy
+487
New +$31K ﹤0.01% 4958

Other funds holding EDSA

Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Scotia Capital
Scotia Capital Toronto, Ontario, Canada $28.7B AUM 25.13% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Jane Street's EDSA Position: Q3 2026 in Review

Jane Street reduced its Edesa Biotech (EDSA) stake by 31% in Q3 2026, selling an estimated $118K and leaving 49,992 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #9972.

Jane Street first reported a position in EDSA in Q3 2018 and has held it in 4 quarters since. The position peaked at $605K in Q1 2026. 18 funds tracked by Wall St. Rank hold EDSA as of Q3 2026.

  • Jane Street held 49,992 shares of Edesa Biotech worth $210K as of Q3 2026.
  • Jane Street sold 22,473 Edesa Biotech shares in Q3 2026, an estimated $118K.
  • Edesa Biotech made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9972 holding.
  • Jane Street first reported a position in Edesa Biotech in Q3 2018 and has held it in 4 quarters since.
  • Jane Street's Edesa Biotech position peaked at $605K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Edesa Biotech as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.